These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 33738250)

  • 1. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
    Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
    Front Oncol; 2021; 11():603882. PubMed ID: 33738250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients.
    Song L; Zhu Z; Mao L; Li X; Han W; Du H; Wu H; Song W; Jin Z
    Front Oncol; 2020; 10():369. PubMed ID: 32266148
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting anaplastic lymphoma kinase rearrangement status in patients with non-small cell lung cancer using a machine learning algorithm that combines clinical features and CT images.
    Hao P; Deng BY; Huang CT; Xu J; Zhou F; Liu ZX; Zhou W; Xu YK
    Front Oncol; 2022; 12():994285. PubMed ID: 36338735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning based on clinico-biological features integrated
    Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
    Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
    Front Immunol; 2022; 13():859323. PubMed ID: 35572597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
    Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
    Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of
    Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
    Transl Cancer Res; 2019 Sep; 8(5):1741-1749. PubMed ID: 35116924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
    Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
    Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron Emission Tomography/Magnetic Resonance Imaging Radiomics in Predicting Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Tang X; Liang J; Xiang B; Yuan C; Wang L; Zhu B; Ge X; Fang M; Ding Z
    Front Oncol; 2022; 12():803824. PubMed ID: 35186742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-Based Radiomic Signature as a Prognostic Factor in Stage IV
    Li H; Zhang R; Wang S; Fang M; Zhu Y; Hu Z; Dong D; Shi J; Tian J
    Front Oncol; 2020; 10():57. PubMed ID: 32133282
    [No Abstract]   [Full Text] [Related]  

  • 15. CT Radiomics Combined With Clinicopathological Features to Predict Invasive Mucinous Adenocarcinoma in Patients With Lung Adenocarcinoma.
    Zhang J; Hao L; Li M; Xu Q; Shi G
    Technol Cancer Res Treat; 2023; 22():15330338231174306. PubMed ID: 37278046
    [No Abstract]   [Full Text] [Related]  

  • 16. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
    Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
    Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
    Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ
    Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
    Zhang Y; Liu H; Chang C; Yin Y; Wang R
    PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding.
    Khodabakhshi Z; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
    Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):713-725. PubMed ID: 37599160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized nomogram for predicting ALK rearrangement status in lung adenocarcinoma patients.
    Song L; Zhu Z; Wu H; Han W; Cheng X; Li J; Du H; Lei J; Sui X; Song W; Jin ZY
    Eur Radiol; 2021 Apr; 31(4):2034-2047. PubMed ID: 33146791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.